These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9674599)
1. Selective suppression of cathepsin L results from elevations in lysosomal pH and is followed by proteolysis of tau protein. Bednarski E; Lynch G Neuroreport; 1998 Jun; 9(9):2089-94. PubMed ID: 9674599 [TBL] [Abstract][Full Text] [Related]
2. Cytosolic proteolysis of tau by cathepsin D in hippocampus following suppression of cathepsins B and L. Bednarski E; Lynch G J Neurochem; 1996 Nov; 67(5):1846-55. PubMed ID: 8863489 [TBL] [Abstract][Full Text] [Related]
3. Suppression of cathepsins B and L causes a proliferation of lysosomes and the formation of meganeurites in hippocampus. Bednarski E; Ribak CE; Lynch G J Neurosci; 1997 Jun; 17(11):4006-21. PubMed ID: 9151717 [TBL] [Abstract][Full Text] [Related]
4. Lysosomal activation is a compensatory response against protein accumulation and associated synaptopathogenesis--an approach for slowing Alzheimer disease? Bendiske J; Bahr BA J Neuropathol Exp Neurol; 2003 May; 62(5):451-63. PubMed ID: 12769185 [TBL] [Abstract][Full Text] [Related]
8. Aβ42-mediated proteasome inhibition and associated tau pathology in hippocampus are governed by a lysosomal response involving cathepsin B: Evidence for protective crosstalk between protein clearance pathways. Farizatto KLG; Ikonne US; Almeida MF; Ferrari MFR; Bahr BA PLoS One; 2017; 12(8):e0182895. PubMed ID: 28797057 [TBL] [Abstract][Full Text] [Related]
9. Differentiation-induced changes in the content, secretion, and subcellular distribution of lysosomal cathepsins in the human colon cancer HT-29 cell line. De Stefanis D; Démoz M; Dragonetti A; Houri JJ; Ogier-Denis E; Codogno P; Baccino FM; Isidoro C Cell Tissue Res; 1997 Jul; 289(1):109-17. PubMed ID: 9182605 [TBL] [Abstract][Full Text] [Related]
10. Endocytosis by liver cells during suppression of intralysosomal proteolysis. Korolenko TA; Rukavishnikova EV; Safina AF; Dushkin MI; Mynkina GI Biol Chem Hoppe Seyler; 1992 Jul; 373(7):573-80. PubMed ID: 1515086 [TBL] [Abstract][Full Text] [Related]
11. Experimentally induced lysosomal dysfunction disrupts processing of hypothalamic releasing factors. Bi X; Pinkstaff J; Nguyen K; Gall CM; Lynch G J Comp Neurol; 1998 Nov; 401(3):382-94. PubMed ID: 9811115 [TBL] [Abstract][Full Text] [Related]
12. Regulation of the activity of lysosomal cysteine proteinases by pH-induced inactivation and/or endogenous protein inhibitors, cystatins. Turk B; Bieth JG; Björk I; Dolenc I; Turk D; Cimerman N; Kos J; Colic A; Stoka V; Turk V Biol Chem Hoppe Seyler; 1995 Apr; 376(4):225-30. PubMed ID: 7626231 [TBL] [Abstract][Full Text] [Related]
13. Collagenolytic cysteine proteinases of bone tissue. Cathepsin B, (pro)cathepsin L and a cathepsin L-like 70 kDa proteinase. Delaissé JM; Ledent P; Vaes G Biochem J; 1991 Oct; 279 ( Pt 1)(Pt 1):167-74. PubMed ID: 1930136 [TBL] [Abstract][Full Text] [Related]
14. A selective colorimetric assay for cathepsin L using Z-Phe-Arg-4-methoxy-beta-naphthylamide. Kamboj RC; Pal S; Raghav N; Singh H Biochimie; 1993; 75(10):873-8. PubMed ID: 8312391 [TBL] [Abstract][Full Text] [Related]
15. Specific assay method for the activities of cathepsin L-type cysteine proteinases. Inubushi T; Kakegawa H; Kishino Y; Katunuma N J Biochem; 1994 Aug; 116(2):282-4. PubMed ID: 7822244 [TBL] [Abstract][Full Text] [Related]
16. Inhibitions of cathepsin B and cathepsin L by E-64 in vivo. II. Incorporation of [3H]E-64 into rat liver lysosomes in vivo. Hashida S; Kominami E; Katunuma N J Biochem; 1982 Apr; 91(4):1373-80. PubMed ID: 7096292 [TBL] [Abstract][Full Text] [Related]
17. Characterization of CAA0225, a novel inhibitor specific for cathepsin L, as a probe for autophagic proteolysis. Takahashi K; Ueno T; Tanida I; Minematsu-Ikeguchi N; Murata M; Kominami E Biol Pharm Bull; 2009 Mar; 32(3):475-9. PubMed ID: 19252298 [TBL] [Abstract][Full Text] [Related]
18. Discrimination of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, and mammalian cathepsins B and L, by a pH-inducible fluorogenic substrate of trypanosomal cysteine proteinases. Serveau C; Lalmanach G; Hirata I; Scharfstein J; Juliano MA; Gauthier F Eur J Biochem; 1999 Jan; 259(1-2):275-80. PubMed ID: 9914503 [TBL] [Abstract][Full Text] [Related]
19. Study of thiol proteases of normal human skin fibroblasts. Khalfan HA Cell Biochem Funct; 1991 Jan; 9(1):55-62. PubMed ID: 2065436 [TBL] [Abstract][Full Text] [Related]
20. Lysosomal protease inhibitors induce meganeurites and tangle-like structures in entorhinohippocampal regions vulnerable to Alzheimer's disease. Bi X; Zhou J; Lynch G Exp Neurol; 1999 Aug; 158(2):312-27. PubMed ID: 10415139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]